| ID | 68786 |
| Title Alternative | 肝細胞癌におけるアテゾリズマブ・ベバシズマブ併用療法後のコンバージョン治療に関する検討
|
| FullText URL | |
| Author |
KIKUCHI, Tatsuya
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
|
| Note | 岡山大学審査学位論文
Kikuchi T, Takeuchi Y, Nouso K, et al. Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab. Liver Int. 2024; 44: 1456-1463. doi:10.1111/liv.15907
|
| Published Date | 2025-03-25
|
| Content Type |
Thesis or Dissertation
|
| Grant Number | 甲第7226号
|
| Granted Date | 2025-03-25
|
| Thesis Type |
Doctor of Philosophy in Medical Science
|
| Grantor | 岡山大学
|
| Thesis FullText |
Thesis or Dissertation (See FullText URL)
|
| Related Url | isVersionOf https://doi.org/10.1111/liv.15907
|
| language |
English
|
| File Version | ETD
|
| Grant ID | 15301甲第7226号
|
| PubMed ID | |
| Copyright Holders | © 2024 The Authors.
|
| DOI | |
| License | http://creativecommons.org/licenses/by-nc-nd/4.0/
|
